fbpx Skip to main content
 

Search

Janssen Search

Search results

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 5 OF 77

Pages

Our Fight Against Alzheimer’s September is World Alzheimer’s Month, a tradition that began in 2012 to draw attention to this devastating brain disease. It is easy to get discouraged about Alzheimer’s. Worldwide, nearly 44 million people have Alzheimer’s ...

ASCO: The Annual Meeting that Strengthens Our Resolve to Eliminate Cancer   Every year, I look forward to attending the ASCO Annual Meeting that brings together over 40,000 in the field of oncology. I cannot help but be inspired by the many people who ...

PAMELA BRADT, M.D. VICE PRESIDENT IMMUNOLOGY DATA SCIENCE Pamela Bradt, M.D., is Vice President, Head of Data Science for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In this role, Pam is responsible for driving Data Science ...

JAN WEHKAMP, M.D. VICE PRESIDENT GASTROENTEROLOGY DISEASE AREA LEADER Jan Wehkamp, M.D. is Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC. In this role, he is responsible ...

As Global Head of the Janssen Prevention Center, Frank de Wolf is responsible for driving research to develop new concepts for disease prevention that will extend the healthy life span. He was appointed to this position in March 2017. Frank has been Head ...

Late Development “Our goal is to evolve the next wave of cancer therapies into comprehensive regimens that combine several approaches tailored to patients’ individual needs.” Craig Tendler, M.D. Vice President, Late Development and Global Medical Affairs ...

JOEL GRESHOCK VICE PRESIDENT DATA SCIENCES, ONCOLOGY Joel Greshock  is Vice President, Data Sciences, Oncology at Janssen Research & Development. In this position, he is responsible for creating unique and actionable medical insights using large and ...

Developing New Treatments for Neglected Tropical Diseases We Recognize the Urgent Need for Innovative Treatment Options In 2012, Johnson & Johnson signed the London Declaration on Neglected Tropical Diseases, a multilateral partnership to eliminate or ...

Our Vision to Eliminate Prostate Cancer through a Multi-Pronged Approach   Prostate cancer is the second most common cancer and the fourth leading cause of cancer death in men worldwide, with an incidence of approximately 1.4 million and mortality of ...

Article Type:  Infectious Diseases & Vaccines Tackling Infectious Diseases in China For several years Janssen has partnered with Tsinghua University in Beijing, China to host a Public Health Day that featured academia, leading government officials and ...

762 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 5 OF 77

Pages